Vitespen

**Semantic type:** Immunologic Factor|Pharmacologic Substance

**Definition:** An autologous cancer vaccine derived from tumor-specific gp96 heat shock proteins. Heat shock proteins chaperone peptides through the endoplasmic reticulum, are key regulators of dendritic cell maturation, migration and antigen processing, and are involved in T-cell activation. (NCI04)

**Synonyms:** - Autologous gp96 Heat Shock Protein Peptide Complex Vaccine - HSP gp96-Peptide Complex - HSPPC-96 - Heat Shock Protein Peptide Complex-96 - Oncophage - Oncophage - Recombinant Human Tumor Rejection Antigen 1 - VITESPEN - gp96 HSP-Peptide Complex - gp96 HSP-peptide complex - gp96 Heat Shock Protein-Peptide Complex - gp96 heat shock protein-peptide complex vaccine - vitespen